MDMA trauma therapy for couples - Anne Wagner (Finnish subtitles)

Dr. Anne Wagner, the leader of the mental health innovation centre Remedy, has researched MDMA psychotherapy in the context of cognitive-behavioral conjoint therapy (CBCT) for the treatment posttraumatic stress disorder. Instead of the more typical approach where just the person suffering from trauma gets the treatment, in the context of her research, both the person and their partner received MDMA therapy.
In this interview, she also talks about the qualities of a good MDMA therapist, integrating psychedelic experiences, the challenges related to the wider implementation of MDMA therapy and integrating the modality into our health care systems, the risk of MDMA only becoming available for the affluent, how she became involved with MDMA therapy and the future of MDMA.
Anne Wagner, CPscyh, PhD, is a clinical psychologist and researcher who is committed to helping understand and improve trauma recovery. She is also the founder of Remedy, a mental health innovation community. She is Adjunct Professor at the Department of Psychology and an Associate Member of the Yeates School of Graduate Studies at Ryerson University. Anne completed a Canadian Institutes of Health Research Postdoctoral Fellowship at Ryerson University, and is the 2019 recipient of the Clinical Section of the Canadian Psychological Association’s Early Career Scientist Practitioner Award. She is currently the Past-Chair of the Traumatic Stress Section of the Canadian Psychological Association and her work has been funded by the Multidisciplinary Association for Psychedelic Studies, the Canadian Institutes of Health Research, the Ontario Trillium Foundation, the Canadian Foundation for AIDS Research, and the Canadian Armed Forces.
00:00:00 Introduction
00:00:23 Why is MDMA therapy interesting?
00:01:46 MDMA assisted cognitive-behavioral conjoint therapy
00:04:00 The role of psychotherapy in MDMA-therapy
00:04:31 What does MDMA bring to CBCT?
00:05:51 How did you get involved in the the field?
00:08:02 Do the therapist's personal experiences with MDMA or altered states of consciousness play a role?
00:11:05 What does it take to be a good MDMA therapist
00:12:08 Does being a good MDMA therapist differ from being a good therapist in general?
00:12:52 Is MDMA-therapy easy?
00:14:09 Integrating the experiences
00:15:07 Can MDMA have a preventative effect on PTSD?
00:16:46 Is MDMA therapy overhyped?
00:17:46 The main challenges related to the wider implementation of MDMA therapy
00:18:32 On integrating MDMA therapy in our health care systems
00:20:26 Is there a risk that MDMA therapy will only become available for the affluent?
00:21:14 Has your work encountered resistance?
00:23:23 The biggest challenges you've had
00:25:05 The future of MDMA
Camera and sound: Kasakka Media, kasakka.fi
Interview, editing and Finnish subtitles: Henry Soinnunmaa
All the lectures of the event are now also available in a playlist. Finnish subtitles for them will be available later. Watch: • Psykedeelinäkymiä 2019...
• • • • •
The Finnish Association for Psychedelic Research is a multidisciplinary association founded in December 2016 with the goals of promoting scientific research related to psychedelics and the availability of accessible information based on such research.
More on Psyty: psyty.fi
Our social media channels:
/ psyty
/ psytyfi
/ psyty
/ psyty

[@C.J.Enholm]

Anne Wagner is one of the most eloquent researcher in the field. Thank you for this high quality interview.

[@Bigmikey78]

Very helpful video and information. Thank you for taking the time to create it. I'm interested in this type of therapy but on the other side o Canada :)